272 related articles for article (PubMed ID: 32336287)
1. Impact of symptom severity in patients with diarrhoea-predominant irritable bowel syndrome (IBS-D): results from two separate surveys of HCPs and patients with IBS-D.
Emmanuel A; Goosey RW; Wiseman G; Baker S; Törnblom H
BMC Gastroenterol; 2020 Apr; 20(1):127. PubMed ID: 32336287
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): study protocol for a randomised controlled trial.
Leighton MP; Lam C; Mehta S; Spiller RC
Trials; 2013 Jan; 14():10. PubMed ID: 23302220
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Symptoms, Healthcare Utilization, and Treatment in Diagnosed and Undiagnosed Individuals With Diarrhea-Predominant Irritable Bowel Syndrome.
Sayuk GS; Wolf R; Chang L
Am J Gastroenterol; 2017 Jun; 112(6):892-899. PubMed ID: 28094313
[TBL] [Abstract][Full Text] [Related]
4. Discriminant and convergent validity of the GSRS-IBS symptom severity measure for irritable bowel syndrome: A population study.
Ljótsson B; Jones M; Talley NJ; Kjellström L; Agréus L; Andreasson A
United European Gastroenterol J; 2020 Apr; 8(3):284-292. PubMed ID: 32213021
[TBL] [Abstract][Full Text] [Related]
5. An examination of subgroup classification in irritable bowel syndrome patients over time: a prospective study.
Penny KI; Smith GD; Ramsay D; Steinke DT; Kinnear M; Penman ID
Int J Nurs Stud; 2008 Dec; 45(12):1715-20. PubMed ID: 18829027
[TBL] [Abstract][Full Text] [Related]
6. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
Everitt H; Landau S; Little P; Bishop FL; O'Reilly G; Sibelli A; Holland R; Hughes S; Windgassen S; McCrone P; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
Health Technol Assess; 2019 Apr; 23(17):1-154. PubMed ID: 31042143
[TBL] [Abstract][Full Text] [Related]
7. Latent structure of irritable bowel syndrome symptom severity.
Jasper F; Egloff B; Roalfe A; Witthöft M
World J Gastroenterol; 2015 Jan; 21(1):292-300. PubMed ID: 25574104
[TBL] [Abstract][Full Text] [Related]
8. Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation.
Singh P; Staller K; Barshop K; Dai E; Newman J; Yoon S; Castel S; Kuo B
World J Gastroenterol; 2015 Jul; 21(26):8103-9. PubMed ID: 26185382
[TBL] [Abstract][Full Text] [Related]
9. Subtypes of irritable bowel syndrome based on abdominal pain/discomfort severity and bowel pattern.
Heitkemper M; Cain KC; Shulman R; Burr R; Poppe A; Jarrett M
Dig Dis Sci; 2011 Jul; 56(7):2050-8. PubMed ID: 21290181
[TBL] [Abstract][Full Text] [Related]
10. Alosetron for severe diarrhea-predominant irritable bowel syndrome: improving patient outcomes.
Bleser S
Curr Med Res Opin; 2011 Mar; 27(3):503-12. PubMed ID: 21208139
[TBL] [Abstract][Full Text] [Related]
11. Importance of diarrhea in evaluating constipation in irritable bowel syndrome clinical studies.
Basseri RJ; Kunkel D; Low K; Conklin JL; Pimentel M
J Clin Gastroenterol; 2011 Oct; 45(9):790-3. PubMed ID: 21301356
[TBL] [Abstract][Full Text] [Related]
12. Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized, multiple-blind, placebo-controlled trial.
Liang SB; Han M; Cheng HJ; Zhang QY; Zhang NW; Jia BY; Robinson N; Liu JP
Trials; 2022 Mar; 23(1):226. PubMed ID: 35313933
[TBL] [Abstract][Full Text] [Related]
13. Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.
Dove LS; Lembo A; Randall CW; Fogel R; Andrae D; Davenport JM; McIntyre G; Almenoff JS; Covington PS
Gastroenterology; 2013 Aug; 145(2):329-38.e1. PubMed ID: 23583433
[TBL] [Abstract][Full Text] [Related]
14. A retrospective and prospective 12-month observational study of the socioeconomic burden of moderate to severe irritable bowel syndrome with constipation in Spain.
Mearin F; Caballero AM; Serra J; Brotons C; Tantiñà A; Fort E; Martínez-Cerezo FJ; Perelló A; Sánchez-Antolín G; Rey E; Angós Musgo R; Berdier R; Gómez-Rodríguez B; Clavé P; García-Alonso M; Torán-Monserrat P; Tack J
Gastroenterol Hepatol; 2019 Mar; 42(3):141-149. PubMed ID: 30612850
[TBL] [Abstract][Full Text] [Related]
15. Gender differences in gastrointestinal, biopsychosocial and healthcare-seeking behaviors in Chinese patients with irritable bowel syndrome predominant with diarrhea.
Fan W; Chen Y; Fang X; Zhu L; Fei G; Lu J; Li X
BMC Gastroenterol; 2024 Mar; 24(1):102. PubMed ID: 38481138
[TBL] [Abstract][Full Text] [Related]
16. Understanding symptom burden and attitudes to irritable bowel syndrome with diarrhoea: Results from patient and healthcare professional surveys.
Törnblom H; Goosey R; Wiseman G; Baker S; Emmanuel A
United European Gastroenterol J; 2018 Nov; 6(9):1417-1427. PubMed ID: 30386615
[TBL] [Abstract][Full Text] [Related]
17. Economic burden of moderate to severe irritable bowel syndrome with constipation in six European countries.
Tack J; Stanghellini V; Mearin F; Yiannakou Y; Layer P; Coffin B; Simren M; Mackinnon J; Wiseman G; Marciniak A;
BMC Gastroenterol; 2019 May; 19(1):69. PubMed ID: 31064345
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a Chinese Herbal Medicine in Providing Adequate Relief of Constipation-predominant Irritable Bowel Syndrome: A Randomized Controlled Trial.
Bensoussan A; Kellow JE; Bourchier SJ; Fahey P; Shim L; Malcolm A; Boyce P
Clin Gastroenterol Hepatol; 2015 Nov; 13(11):1946-54.e1. PubMed ID: 26133902
[TBL] [Abstract][Full Text] [Related]
19. Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea.
Buono JL; Carson RT; Flores NM
Health Qual Life Outcomes; 2017 Feb; 15(1):35. PubMed ID: 28196491
[TBL] [Abstract][Full Text] [Related]
20. Faecal bile acids and colonic bile acid membrane receptor correlate with symptom severity of diarrhoea-predominant irritable bowel syndrome: A pilot study.
Wei W; Wang H; Zhang Y; Zhang Y; Niu B; Chen S; Zhang W; Yao S
Dig Liver Dis; 2021 Sep; 53(9):1120-1127. PubMed ID: 34053874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
